Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | THPO | P40225 | 1/20 | 0.47 |
| ▸ | MTOR | P42345 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CETP | P11597 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | UBE2N | P61088 | 1/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8403161 | 0.84 | SMN1; SMN2 (0.36) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL27517244 | 0.78 | LMNA (0.48) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL27496690 | 0.78 | LMNA (0.48) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL27916868 | 0.78 | LMNA (0.48) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL30189390 | 0.78 | LMNA (0.48) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL23706318 | 0.78 | LMNA (0.48) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL3690415 | 0.78 | LMNA (0.43) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL7159926 | 0.77 | LMNA (0.46) | LMNACYP2D6SPHK1GMNNPOLB | |
| Phosphine SCHEMBL27845988 | 0.77 | LMNA (0.46) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL6812423 | 0.77 | LMNA (0.46) | LMNACYP2D6SPHK1GMNNPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0957107-B1 | NOVEL COMPOUNDS HAVING ANTIVIRAL ACTIVITY | NISSIN FOOD PRODUCTS LTD (JP) | 2004-07-21 | — | — | EP | disclosed |
| WO-2003049672-A2 | METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUS-MEDIATED DISEASE | MICROBIOTIX, INC. (US) | 2003-06-19 | — | — | WO | disclosed |
| WO-2003041639-A2 | METHODS AND COMPOSITIONS FOR TREATING ROTAVIRUS-MEDIATED DISEASE | MICROBIOTIX, INC. (US) | 2003-05-22 | — | — | WO | disclosed |
| US-6541461-B2 | Treating viral infection; obtain mamal, administer vircide, monitor response to viricide | NISSIN FOOD PRODUCTS CO., LTD. (JP) | 2003-04-01 | — | — | US | disclosed |
| US-20020077472-A1 | Novel compounds having antiviral activity | NISSIN FOOD PRODUCTS CO., LTD. (JP) | 2002-06-20 | — | — | US | disclosed |
| US-6337390-B1 | MONOSACCHARIDE LIPID LINKED TO ANOMERIC CARBON OF SIALIC ACID OR KDN | NISSAN FOOD PRODUCTS CO., LTD. (JP) | 2002-01-08 | — | — | US | disclosed |
| EP-0957107-A1 | NOVEL COMPOUNDS HAVING ANTIVIRAL ACTIVITY | NISSIN FOOD PRODUCTS CO., LTD. (JP) | 1999-11-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020077472-A1 | Novel compounds having antiviral activity | ST6GAL1, SIGLEC7, NEU2 | LMNA 889/4885CYP2D6 3722/4885SPHK1 192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.